Please assess the completion status of the following clinical trial:

Trial Title: OTC Naproxen and Acetaminophen Anti-Inflammatory Action in Dental Implant Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subject requires surgical placement of one or two (adjacent) dental implants~* Ability to read and sign informed consent~* Males and females for 18-75 years of age~* Non-smokers~* Negative urine drug screen~Exclusion Criteria~* Advanced periodontal disease (\>20% Clinical Attachment Loss \>20% radiographic bone loss)~* History of bisphosphonate usage~* Medical history or medical condition that makes any of the study medications (naproxen sodium, acetaminophen, tramadol, etc.) inappropriate treatment options including any scheduled or recent cardiac procedures (within 6 months), a history of GI ulcers, liver or kidney disease, and anticoagulant or lithium intake.~* History of an allergic reaction to any pain reliever/fever reducer~* Contraindication to opioid use~* Positive urine drug screen for drugs of abuse unless on stable doses of a non-analgesic drug for a legitimate medical purpose~* Pregnancy - A urine pregnancy test will be performed immediately before the scheduled surgery on all women of child-bearing potential~* Local or systemic diseases that affects wound healing and inflammatory biomarkers (diabetes, autoimmune (rheumatoid arthritis), or inflammatory disorders - osteoarthritis is allowed).~* Smokers on this pilot study because it can affect levels of inflammatory biomarkers - a urine cotinine test will be performed immediately prior to the scheduled surgery on all subjects even if participant denies smoking history~* History of systemic steroid use over 2 weeks within last 2 years.~* Poor oral hygiene on a non-compliant individual.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Naproxen sodium (Type: EXPERIMENTAL): Naproxen sodium 440 mg followed by naproxen sodium 220 mg q 8h (max 660 mg/day)
- Acetaminophen (Type: ACTIVE_COMPARATOR): Acetaminophen 1000 mg followed by acetaminophen 1000 mg q 6h (max 3000 mg/day according to Tylenol package insert)

Based on this trial design, predict the completion outcome and termination type (if applicable).